The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
Open accessAbstract
Vα24-invariant NKT cells inhibit tumor growth by targeting tumor-associated macrophages (TAMs). Tumor progression therefore requires that TAMs evade NKT cell activity through yet-unknown mechanisms. Here we report that a subset of cells in neuroblastoma (NB) cell lines and primary tumors expresses membrane-bound TNF-α (mbTNF-α). These proinflammatory tumor cells induced production of the chemokine CCL20 from TAMs via activation of the NF-κB signaling pathway, an effect that was amplified in hypoxia. Flow cytometry analyses of human primary NB tumors revealed selective accumulation of CCL20 in TAMs. Neutralization of the chemokine inhibited in vitro migration of NKT cells toward tumor-conditioned hypoxic monocytes and localization of NKT cells to NB grafts in mice. We also found that hypoxia impaired NKT cell viability and function. Thus, CCL20-producing TAMs served as a hypoxic trap for tumor-infiltrating NKT cells. IL-15 protected antigen-activated NKT cells from hypoxia, and transgenic expression of IL-15 in adoptively transferred NKT cells dramatically enhanced their antimetastatic activity in mice. Thus, tumor-induced chemokine production in hypoxic TAMs and consequent chemoattraction and inhibition of NKT cells represents a mechanism of immune escape that can be reversed by adoptive immunotherapy with IL-15-transduced NKT cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Di Stasi, A., Tey, S.-K., Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof, K., Liu, E., Durett, A. G., Grilley, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106152 · Cited by 1,512
Self-citationThe CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“The protective effect of these cytokines on proliferating rather than quiescent NKT cells was consistent with similar observations in T cells, which have previously been shown to switch to glycolysis upon antigenic stimulation and to require less oxygen (34, 35).”
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241
Pietras, A., Hansford, L. M., Johnsson, A. S., Bridges, E., Sjölund, J., Gisselsson, D., Rehn, M., Beckman, S., Noguera, R., Navarro, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904606106 · Cited by 135
Research works printed but not linked: 56
- 10.1038/35080111 · doi:10.1038/35080111
- Swann, 2004, Immunol Cell Biol., 82, 323, 10.1111/j.0818-9641.2004.01254.x · DOI
- Swann, 2007, Curr Top Microbiol Immunol., 314, 293, 10.1007/978-3-540-69511-0_12 · DOI
- Berzofsky, 2009, Curr Mol Med., 9, 667, 10.2174/156652409788970706 · DOI
- Yanagisawa, 2002, J Immunol., 168, 6494, 10.4049/jimmunol.168.12.6494 · DOI
- Tahir, 2001, J Immunol., 167, 4046, 10.4049/jimmunol.167.7.4046 · DOI · Paper page
- 10.1084/jem.20021650 · DOI · Paper page
- 10.1084/jem.20031462 · DOI · Paper page
- 10.1158/1078-0432.CCR-05-0877 · DOI · Paper page
- 10.1200/JCO.2006.08.5787 · DOI · Paper page
- Metelitsa, 2001, J Immunol., 167, 3114, 10.4049/jimmunol.167.6.3114 · DOI · Paper page
- 10.1172/JCI37869 · DOI · Paper page
- 10.1172/JCI31422 · DOI · Paper page
- 10.1172/JCI36264 · DOI · Paper page
- 10.1038/ni.1942 · DOI · Paper page
- O’Konek, 2011, J Clin Invest., 121, 683, 10.1172/JCI42314 · DOI
- 10.1016/j.critrevonc.2007.07.004 · DOI · Paper page
- 10.1007/s10555-006-9001-7 · DOI · Paper page
- 10.1016/j.cell.2010.01.025 · DOI · Paper page
- 10.1182/blood-2001-12-0196 · DOI · Paper page
- 10.1016/S1471-4906(02)02323-2 · DOI
- Thomas, 2003, J Immunol., 171, 2571, 10.4049/jimmunol.171.5.2571 · DOI · Paper page
- 10.1172/JCI30751 · DOI
- Yahata, 2002, J Immunol., 169, 204, 10.4049/jimmunol.169.1.204 · DOI · Paper page
- Giassi, 2008, Exp Biol Med (Maywood )., 233, 997, 10.3181/0802-RM-70 · doi:10.3181/0802-rm-70
- 10.1189/jlb.0607349 · DOI
- Goillot, 1992, Cancer Res., 52, 3194
- Seeger RC, Atkinson J, Reynolds CP. Neuroblastoma. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichsenbaum RR, eds.Cancer Medicine . Philadelphia, Pennsylvania, USA: Lea and Febiger; 1996:2991–3020.
- 10.1016/0014-4827(73)90561-2 · DOI · Paper page
- Krauss, 2001, Immunity., 15, 497, 10.1016/S1074-7613(01)00205-9 · DOI · Paper page
- 10.1016/j.immuni.2007.07.008 · DOI · Paper page
- 10.1084/jem.20061097 · DOI · Paper page
- Li, 2007, J Immunol., 178, 5899, 10.4049/jimmunol.178.9.5899 · DOI · Paper page
- 10.1182/blood-2009-02-205492 · DOI
- 10.1182/blood-2010-06-290643 · DOI
- 10.1016/j.clim.2011.03.002 · DOI
- Baev, 2004, Blood., 104, 4150, 10.1182/blood-2004-04-1629 · DOI
- 10.1038/ni837 · DOI · Paper page
- Gordy, 2011, J Immunol., 187, 6335, 10.4049/jimmunol.1003965 · DOI · Paper page
- 10.1182/blood-2006-06-029173 · DOI
- 10.1038/nature02924 · DOI · Paper page
- 10.1016/j.ejca.2006.01.012 · DOI · Paper page
- Affara, 2007, Cell., 129, 25, 10.1016/j.cell.2007.03.029 · DOI
- 10.1016/S0140-6736(07)60983-0 · DOI · Paper page
- 10.1016/S1470-2045(03)01196-3 · DOI · Paper page
- 10.1093/annonc/mdn054 · DOI · Paper page
- Friedberg, 2008, Leuk Lymphoma., 49, 902, 10.1080/10428190801950033 · doi:10.1080/10428190801950033
- 10.1084/jem.20050953 · DOI · Paper page
- Waldmann, 2006, Nat Rev Immunol., 6, 595, 10.1038/nri1901 · DOI · Paper page
- 10.1189/jlb.1107778 · DOI
- 10.1016/j.it.2006.05.003 · DOI · Paper page
- 10.1182/blood-2004-11-4564 · DOI · Paper page
- 10.1016/j.bbmt.2007.04.005 · DOI · Paper page
- 10.1182/blood-2007-02-072843 · DOI
- Reynolds, 1988, Prog Clin Biol Res., 271, 291
- 10.1073/pnas.172398399 · DOI · Paper page
Cited by
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Cheung, N.-K. V., & Dyer, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3526 · Cited by 801
Humanized Mouse Models of Clinical Disease
Walsh, N. C., Kenney, L. L., Jangalwe, S., Aryee, K.-E., Greiner, D. L., Brehm, M. A., & Shultz, L. D. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100332 · Cited by 562
Tumor-Associated Macrophages: Implications in Cancer Immunotherapy
Petty, A. J., & Yang, Y. (2017) · Immunotherapy · doi:10.2217/imt-2016-0135 · Cited by 363
Neuroblastoma: Molecular Pathogenesis and Therapy
Louis, C. U., & Shohet, J. M. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-011514-023121 · Cited by 354
Reduction of MDSCs with all-trans retinoic acid improves CAR therapy efficacy for sarcomas
Long, A. H., Highfill, S. L., Cui, Y., Smith, J. P., Walker, A. J., Ramakrishna, S., El-Etriby, R., Galli, S., Tsokos, M. G., Orentas, R. J., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0230 · Cited by 329
Metadata
- Authors
- Liu, D., Song, L., Wei, J., Courtney, A. N., Gao, X., Marinova, E., Guo, L., Heczey, A., Asgharzadeh, S., Kim, E., Dotti, G., & Metelitsa, L. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-06-01
- Volume
- 122
- Issue
- 6
- Pages
- 2221-2233
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1990075911
- Cited by
- 164
- References
- 7
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. https://app.cochat.ai/papers/10.1172/jci59535
- The paper
- Liu, D., Song, L., Wei, J., Courtney, A. N., Gao, X., Marinova, E., Guo, L., Heczey, A., Asgharzadeh, S., Kim, E., Dotti, G., & Metelitsa, L. S. (2012). IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. Journal of Clinical Investigation. https://doi.org/10.1172/jci59535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.